Skip to content

Simplified Conservative Measures in Managing Morbidly Adherent Placenta in Beni-Suef University

Beni-Suef University Hospital Simplified Conservative Approach for Managing Placenta Accreta Spectrum: RCT

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06465836
Enrollment
172
Registered
2024-06-20
Start date
2024-03-15
Completion date
2025-06-30
Last updated
2024-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Placenta Accreta

Brief summary

To evaluate the efficacy of modified uterine artery ligation and myometrial compression as a conservative measure in improving the prognosis of the morbidly adherent placenta.

Detailed description

According to the International Federation of Gynecology and Obstetrics (FIGO) guidelines, the principal surgical strategy to prevent excessive bleeding related to placenta accreta syndrome is to leave the placenta in situ and perform a primary peripartum hysterectomy at delivery. A hysterectomy may not be preferred by patients wishing to preserve fertility and is detrimental to multiple aspects of the pelvic floor, bowel, and physical functions. Surgical principles in placenta accreta syndrome include avoiding disruption of the hypervascular placenta, stepwise devascularization, early and comprehensive blood product transfusion, and judicious use of interventional radiologic techniques such as vascular embolization. Conservative management describes any approach whereby hysterectomy is avoided

Interventions

PROCEDUREO, lreay suture

bilateral uterine artery ligations as described by O- lreay technique in addition to standard conservative methods. Briefly two large vicryl stitches were passed using a large sized needle below and lateral to the lower edge of the uterine incision angle in anteroposterior direction and then redirected from back to the front through avascular window in the posterior leaf of the broad ligament just lateral to the uterine border taking care to avoid injury to bowel posteriorly or bladder/ureter anteriorly. The stitches were tied securely anteriorly

PROCEDUREmodified O, lreay suture

1. Pack Douglas- pouch with a towel. 2. Straight the used vicryl needle mostly no 1. 3. Try to compress and approximate anterior and posterior uterine walls. 4. Start from anterior to posterior 3- 4 cm medial to lateral uterine margin and then pass from posterior to anterior through avascular area in the broad ligament. And we repeat the procedure on the other side. We can repeat this method of uterine ligation at another different plane if needed.

Sponsors

Nesreen Abdel Fattah Abdullah Shehata
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Randomization will be done by online research randomizer as follows (https://www.randomizer.org/about/ ): 2 Sets of 86 Unique Numbers Per Set Range: From 1 to 172

Intervention model description

Patients will be randomized into two groups. One of two intraoperative surgical interventions that will be evolved during the study period: Group A: In which 86 patients will have bilateral uterine artery ligations as described by the O- lreay technique in addition to standard conservative methods. The stitches were tied securely anteriorly. Group B: which will include 86 patients we will do our simplified approach which include; * After placental separation; try to grasp lower segment, or cervical flap. * Close uterine cavity by continuous vicryl no 1 suture. * Do 3 to 4 mattress sutures as the second layer of the uterus. * Do uterine ligation with compression of the lower uterine segment (Modification of O, lreay suture).

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Gestational age more than 28 weeks as determined by LMP and ultrasound. * Placenta previa as confirmed by ultrasound. * Clinically stable with no or mild vaginal bleeding. * No evidence of fetal compromise. * Patient consent.

Exclusion criteria

* Vaginal bleeding * Medical disorders

Design outcomes

Primary

MeasureTime frameDescription
Amount of blood loss6 hours postoperativelyThe primary outcome for the study is the total volume of blood loss in the intra and postoperative period.

Secondary

MeasureTime frameDescription
Maternal morbidity24 hours post operativelyCoagulopathy, need for massive blood transfusion (\> 4 units), length of hospital stay, and visceral injuries ICU admission and post-operative pain.
Maternal mortality24 hours postoperativelyMaternal death

Other

MeasureTime frameDescription
Gynecological conditions6 monthsGynecological complications as amenorrhea, intrauterine adhesions and niche formation.

Countries

Egypt

Contacts

Primary ContactHamada Ali, A. professor
hamadaashry@yahoo.com0201007240754
Backup Contactnesreen shehata, professor
nesoomar@yahoo.com0201024150605

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026